Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Canada Postdoctoral Research Award (CPRA) program

Direct Payment

$140,000.00

Pharmacological rescue of hERG channel trafficking and cardiac function.

FY 2025-26

Summary
Proteins are essential facilitators of cellular processes. Disrupting a proteins ability to fold has devesting effects on human health. This is particularly true for integral membrane proteins, whose complex biosynthesis and marginal stability makes them highly susceptible to mutation. Small molecules have long been proposed to hold therapeutic potential in treating protein misfolding diseases. These so-called 'correctors' help rescue misfolding by specifically binding to and stabilizing the protein. Despite huge success in treating cystic fibrosis, the therapeutic potential of correctors is yet to be fully realized. We believe that the same principles that make the cystic fibrosis correctors successful can be applied to other protein misfolding diseases, including long QT syndromes. Long QT type-2 is a heart rhythm disorder effecting approximately 1:2500 Canadians. Mutations to the hERG potassium channel disrupt the hearts' ability to recharge, making patients susceptible to life-threatening arrhythmias. Like cystic fibrosis, most long QT mutations cause protein misfolding, raising the possibility for similar corrector-based therapies. Using DNA-encoded library screening, we aim to identify novel hERG correctors capable of rescuing long QT mutants and restoring healthy cardiac function. Studying the mechanisms of these new correctors will provide fundamental insight into hERG and protein misfolding diseases, while opening the door for future development of therapeutics.
Program
Canada Postdoctoral Research Award (CPRA) program
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
537423
Name
Emlaw Johnathon R
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Pharmacological rescue of hERG channel trafficking and cardiac function.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Biophysics; Dna-Encoded Library; Drug Discovery; Herg; Ion Channel; Long Qt Syndrome; Protein Folding; Protein Trafficking
Abstract
Proteins are essential facilitators of cellular processes. Disrupting a proteins ability to fold has devesting effects on human health. This is particularly true for integral membrane proteins, whose complex biosynthesis and marginal stability makes them highly susceptible to mutation. Small molecules have long been proposed to hold therapeutic potential in treating protein misfolding diseases. These so-called 'correctors' help rescue misfolding by specifically binding to and stabilizing the protein. Despite huge success in treating cystic fibrosis, the therapeutic potential of correctors is yet to be fully realized. We believe that the same principles that make the cystic fibrosis correctors successful can be applied to other protein misfolding diseases, including long QT syndromes. Long QT type-2 is a heart rhythm disorder effecting approximately 1:2500 Canadians. Mutations to the hERG potassium channel disrupt the hearts' ability to recharge, making patients susceptible to life-threatening arrhythmias. Like cystic fibrosis, most long QT mutations cause protein misfolding, raising the possibility for similar corrector-based therapies. Using DNA-encoded library screening, we aim to identify novel hERG correctors capable of rescuing long QT mutants and restoring healthy cardiac function. Studying the mechanisms of these new correctors will provide fundamental insight into hERG and protein misfolding diseases, while opening the door for future development of therapeutics.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Emlaw, Johnathon R
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~
Direct Payment - $140,000 Grant (2025-26) | Canada Spends